International safety notice
Paxlovid (nirmatrelvir; ritonavir) – Reminder of life-threatening and fatal drug-drug interactions
Ireland / HPRA · IRL · Mar 21, 2024
Key facts
| Title | Paxlovid (nirmatrelvir; ritonavir) – Reminder of life-threatening and fatal drug-drug interactions |
|---|---|
| Regulator | Ireland / HPRA |
| Country | IRL |
| Brand | Paxlovid (nirmatrelvir; ritonavir) – Reminder of life-threatening and fatal drug-drug interactions |
| Models | 01304, CYP3A |
| Date | Mar 21, 2024 |
At a glance
- No Recall
- No Field safety notice
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1